Ligand Pharmaceuticals LGND
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 189.07 | 40.10 | 76.60 | 2.18 | 20,040 | 45 |
| 2025Q3 | 177.14 | 83.03 | 5.68 | 54,931 | 117 | |
| 2025Q2 | 113.68 | 68.23 | 0.24 | 8,444 | 5 | |
| 2025Q1 | 105.14 | 73.44 | -2.21 | -36,216 | -42 | |
| 2024Q4 | 107.15 | 13.22 | 44.75 | -1.68 | -9,637 | -31 |
| 2024Q3 | 100.09 | -56.17 | 40.42 | -0.41 | 3,143 | -7 |
| 2024Q2 | 84.26 | 29.79 | 15.71 | -2.88 | -19,100 | -52 |
| 2024Q1 | 73.10 | 2.63 | 24.82 | 4.75 | 2,988 | 86 |
| 2023Q4 | 71.42 | -36.27 | 75.56 | 1.03 | -5,479 | 18 |
| 2023Q3 | 59.92 | -30.71 | 38.29 | -0.57 | 3,078 | -10 |
| 2023Q2 | 72.10 | -57.40 | 45.86 | 0.15 | -1,983 | 2 |
| 2023Q1 | 73.56 | 25.47 | 83.04 | 2.33 | 14,205 | 42 |
| 2022Q4 | 66.80 | -82.44 | -1.05 | -20,099 | -17 | |
| 2022Q3 | 86.11 | 104.34 | 0.04 | -19,934 | 0 | |
| 2022Q2 | 89.22 | 106.38 | 63.62 | -0.06 | -11,908 | -1 |
| 2022Q1 | 112.49 | 48.09 | 33.18 | -0.57 | -9,306 | -15 |
| 2021Q4 | 154.46 | -498.59 | -0.21 | 12,734 | -5 | |
| 2021Q3 | 139.32 | 79.74 | 0.50 | 15,707 | 14 | |
| 2021Q2 | 131.19 | 119.79 | 1.12 | 45,739 | 31 | |
| 2021Q1 | 152.45 | 40.66 | 0.66 | 4,715 | 18 |